| Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology G Sturm, F Finotello, F Petitprez, JD Zhang, J Baumbach, WH Fridman, ... Bioinformatics 35 (14), i436-i445, 2019 | 467 | 2019 |
| Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology G Sturm, F Finotello, F Petitprez, JD Zhang, J Baumbach, WH Fridman, ... Bioinformatics 35 (14), i436-i445, 2019 | 467 | 2019 |
| KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor JD Zhang, S Wiemann Bioinformatics 25 (11), 1470-1471, 2009 | 322 | 2009 |
| Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer A Ward, A Balwierz, JD Zhang, M Küblbeck, Y Pawitan, T Hielscher, ... Oncogene 32 (9), 1173-1182, 2013 | 319 | 2013 |
| MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways I Keklikoglou, C Koerner, C Schmidt, JD Zhang, D Heckmann, ... Oncogene 31 (37), 4150, 2012 | 311 | 2012 |
| MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F S Jurmeister, M Baumann, A Balwierz, I Keklikoglou, A Ward, S Uhlmann, ... Molecular and cellular biology 32 (3), 633-651, 2012 | 281 | 2012 |
| miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer S Uhlmann, JD Zhang, A Schwäger, H Mannsperger, Y Riazalhosseini, ... Oncogene 29 (30), 4297-4306, 2010 | 249 | 2010 |
| Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer S Uhlmann, H Mannsperger, JD Zhang, EÁ Horvat, C Schmidt, ... Molecular systems biology 8 (1), 570, 2012 | 212 | 2012 |
| Assessment of network module identification across complex diseases S Choobdar, ME Ahsen, J Crawford, M Tomasoni, T Fang, D Lamparter, ... Nature Methods 16 (9), 843-852, 2019 | 190 | 2019 |
| An introduction to machine learning S Badillo, B Banfai, F Birzele, II Davydov, L Hutchinson, T Kam‐Thong, ... Clinical Pharmacology & Therapeutics 107 (4), 871-885, 2020 | 187 | 2020 |
| White-to-brown metabolic conversion of human adipocytes by JAK inhibition A Moisan, YK Lee, JD Zhang, CS Hudak, CA Meyer, M Prummer, ... Nature cell biology 17 (1), 57-67, 2015 | 179 | 2015 |
| 14-3-3ζ turns TGF-βs function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 J Xu, S Acharya, O Sahin, Q Zhang, Y Saito, J Yao, H Wang, P Li, L Zhang, ... Cancer Cell 27 (2), 177-192, 2015 | 171 | 2015 |
| Localization‐and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32. 31 F Haller, A von Heydebreck, JD Zhang, B Gunawan, C Langer, ... The Journal of Pathology: A Journal of the Pathological Society of Great
, 2010 | 157 | 2010 |
| A novel orally available small molecule that inhibits hepatitis B virus expression H Mueller, S Wildum, S Luangsay, J Walther, A Lopez, P Tropberger, ... Journal of hepatology 68 (3), 412-420, 2018 | 103 | 2018 |
| Plasma microRNA profiles for bladder cancer detection L Adam, MF Wszolek, CG Liu, W Jing, L Diao, A Zien, JD Zhang, ... Urologic Oncology: Seminars and Original Investigations 31 (8), 1701-1708, 2013 | 97 | 2013 |
| MicroRNAs: master regulators of drug resistance, stemness, and metastasis U Raza, JD Zhang, Ö Şahin Journal of molecular medicine 92 (4), 321-336, 2014 | 86 | 2014 |
| Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity JD Zhang, N Berntenis, A Roth, M Ebeling The pharmacogenomics journal 14 (3), 208-216, 2014 | 76 | 2014 |
| Effects of copper on CHO cells: insights from gene expression analyses IH Yuk, JD Zhang, M Ebeling, M Berrera, N Gomez, S Werz, C Meiringer, ... Biotechnology progress 30 (2), 429-442, 2014 | 59 | 2014 |
| The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. JD Raza, U and Saatci, {\"O} and Uhlmann, S and Ansari, SA and Ey{\"u}po{\"A ... Oncotarget, 2016 | 57 | 2016 |
| ddCt method for qRTPCR data analysis JD Zhang, M Ruschhaupt, R Biczok Citeseer 48 (4), 346-356, 2013 | 52 | 2013 |
Ozgur SahinProfessor and Endowed Chair at Medical University of South CarolinaPatvirtintas el. paštas musc.edu
